Bio-Path Holdings, Inc.
BPTH· OTC
BPTHBio-Path Holdings, Inc.
Filed Jan 13, 2026 · 10-Q · 105 days after period end · 0001663577-26-000009
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2022 |
|---|---|---|---|---|
| Net Income | -$976.00K | -$2.12M | -$3.20M | -$3.54M |
| EPS Diluted | -$0.11 | -$0.70 | -$6.36 | -$0.49 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Sep 30, 2025 · filed Jan 13, 2026 · 105 d after period end
